Drew Hertig, MBA, CLP

5 Followers

8 SlideShares 5 Followers 2 Followings

8 SlideShares 5 Followers 2 Followings

solubility drug delivery foundation drug delivery insoluble drugs pharmacokinetics biopharmaceutics oral drug delivery odd amidon permeability absorption dissolution ddf metabolism drug delivery conference bcs prodrug biopharmaceutical classification system membrane transport adenovirus cidofovir antiviral cmv drug extended release simvastatin api formulation non-dilutive funding business model infectious disease clinic incubator ind alternative funding accelerator lead gap funding

See more

Activity
About

Introduction to the TSRL, Inc. Accelerator Model

8 years ago • 34145 Views

Tsrl modified dosage forms august_non-confidential

7 years ago • 20170 Views

Oral Drug Delivery 2010: A Mechanistic Approach, as Presented by Dr. Gordon Amidon

6 years ago • 1092 Views

Oral Drug Delivery 2009: GI Motility and Transit, as Presented by Dr. Gordon Amidon

6 years ago • 1268 Views

Intestinal Permeability Determination and Absorption of Soluble Drugs, as Presented by Dr. Gordon Amidon

6 years ago • 1574 Views

AngioDefender Patient Brochure

9 years ago • 920 Views

TSRL Fact Sheet_Preclinical Accelerator_June 2016

7 years ago • 20154 Views

Tsrl fact sheet potent dna therapeutics may 2016

7 years ago • 20040 Views

How To Conduct A Business Incubator Feasibility Study

Sandra Cochrane • 12 years ago

Patents & market exclusivity

GMP EDUCATION : Not for Profit Organization • 11 years ago

solubility drug delivery foundation drug delivery insoluble drugs pharmacokinetics biopharmaceutics oral drug delivery odd amidon permeability absorption dissolution ddf metabolism drug delivery conference bcs prodrug biopharmaceutical classification system membrane transport adenovirus cidofovir antiviral cmv drug extended release simvastatin api formulation non-dilutive funding business model infectious disease clinic incubator ind alternative funding accelerator lead gap funding

See more